The FDA announced on 2019-11-18 that Viewray, Inc. is recalling its ViewRay System models 10000 and 20000 due to a potential radiation dose discrepancy in the MRIdian TPDS software. The agency classified this as a Class II voluntary recall.
How to tell if you have it
- Brand: ViewRay
- Product: ViewRay System for radiation treatment
- Model No.: 10000 and 20000
- PN: PN11440 MRIdian System Treatment Planning and Delivery System (TPDS) software
- Model No. 10000 Serial Nos.: 100,104,105,112,113
- Model No. 20000 Serial Nos.: 101,102,107,108,200,201,203,204,206,207,209,211, 213,214,215,216,217,218,221,223,225,227,228,232,238,240,243, 244,247,250
- Distribution: Worldwide, including US states MO, WI, CA, FL, MI, NY, IL, MA, and countries South Korea, Netherlands, Italy, Japan, Germany, UAE, Turkey, France, Israel, Denmark, Switzerland, United Kingdom
The hazard
Registering dose and structures in the treatment delivery workflow could result in an alignment discrepancy between the imported previously delivered dose and the displayed patient anatomy. This misalignment may not be obvious to the user and can cause the software to incorrectly account for previously delivered dose during plan re-optimization, potentially resulting in unexpectedly higher or lower doses than intended.
Context
GovInfoNow's records show Viewray, Inc. has had four other recalls since 2019-03-03, including a 2021-05-04 recall for French/German/Italian language anomalies and a 2020-10-20 recall regarding the risk of burn injury from overheating components. Other recent recalls of similar products include RayStation Software Version 15.2.0/15.1.3 (2025-11-28), RayStation Software Version 17.0.0-17.0.1 (2025-11-28), and RayStation/RayPlan Software 11A (2025-11-28), all citing radiation dose calculation risk.